Fondaparinux Sodium Compared with Enoxaparin Sodium: A Cost-Effectiveness Analysis

Author： Afsane Bjorvatn   Frode Kristiansen  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.5, Iss.2, 2005-01, pp. : 121-130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery

By Sullivan S.D.  

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 605-620

Adis International

Access to resources Recommend Favorite

Fondaparinux Sodium

By Keam S.J.   Goa K.L.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1673-1685

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting

By McCullagh Laura   Tilson Lesley   Walsh Cathal   Barry Michael  

PharmacoEconomics, Vol. 27, Iss. 10, 2009-10 ,pp. : 829-846

Adis International

Access to resources Recommend Favorite

Enoxaparin sodium cost effective for VTE prophylaxis

By  

Inpharma, Vol. 1, Iss. 1546, 2006-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Enoxaparin sodium cost effective for VTE prophylaxis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 507, 2006-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite